UBS’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2014
Q3 | $510K | Sell |
11,978
-1,682
| -12% | -$71.6K | ﹤0.01% | 3160 |
|
2014
Q2 | $845K | Sell |
13,660
-1,711
| -11% | -$106K | ﹤0.01% | 2814 |
|
2014
Q1 | $999K | Buy |
15,371
+1,691
| +12% | +$110K | ﹤0.01% | 2642 |
|
2013
Q4 | $770K | Buy |
13,680
+1,475
| +12% | +$83K | ﹤0.01% | 2781 |
|
2013
Q3 | $748K | Sell |
12,205
-563
| -4% | -$34.5K | ﹤0.01% | 2671 |
|
2013
Q2 | $746K | Buy |
+12,768
| New | +$746K | ﹤0.01% | 2598 |
|